T cells with high PD-1 expression are associated with lower HIV-specific immune responses despite long-term antiretroviral therapy
- 1 January 2020
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 34 (1) , 15-24
Abstract
Objective: We evaluated frequencies of T cells with high PD-1 expression (PD-1HI) before and after long-term effective antiretroviral therapy (ART), and determined if frequencies on-ART correlated positively with measures of HIV persistence and negatively with HIV-specific responses. Methods: We enrolled individuals who started ART during chronic infection and had durable suppression of viremia for at least 4 years (N = 99). We assessed PD-1HI T-cell frequencies at timepoints pre-ART and on-ART using flow cytometry, and evaluated how frequencies on-ART are associated with measures of HIV persistence, HIV-specific immune responses, and immune activation levels. Results: Pre-ART, PD-1HI CD4+ T cells correlated positively with viremia and negatively with CD4+ T-cell count. At year 1 on-ART, %PD-1HI CD4+ T cells decreased but then remained stable at 4 and 6–15 years on-ART, whereas %PD-1HI CD8+ T cells on-ART remained similar to pre-ART. PD-1HI CD4+ T cells correlated positively with HIV DNA pre-ART and on-ART, and with CD4+ T-cell activation on-ART. PD-1HI CD4+ T cells negatively correlated with HIV Gag-specific and Env-specific T-cell responses but not with CMV-specific or EBV-specific responses. PD-1HI CD8+ T cells trended towards a negative correlation with responses to Gag and Env, but not to CMV and EBV. Conclusion: PD-1HI T cells persist in blood despite prolonged suppression on ART, correlate with HIV DNA levels, and are associated with lower HIV-specific T-cell responses but not CMV-specific or EBV-specific responses, suggesting that these cells are HIV-specific. The findings support evaluating PD-1 blockade strategies for their effect on HIV persistence and HIV-specific immunity.Keywords
This publication has 42 references indexed in Scilit:
- High Production Rates Sustain In Vivo Levels of PD-1 high Simian Immunodeficiency Virus-Specific CD8 T Cells in the Face of Rapid ClearanceJournal of Virology, 2013
- In Vivo Blockade of the PD-1 Receptor Suppresses HIV-1 Viral Loads and Improves CD4+ T Cell Levels in Humanized MiceThe Journal of Immunology, 2013
- PD-1 blockade during chronic SIV infection reduces hyperimmune activation and microbial translocation in rhesus macaquesJournal of Clinical Investigation, 2012
- Purging the HIV-1 reservoir through the disruption of the PD-1 pathwayJournal of the International AIDS Society, 2010
- HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferationNature Medicine, 2009
- High antigen levels are the cause of T cell exhaustion during chronic viral infectionProceedings of the National Academy of Sciences, 2009
- Enhancing SIV-specific immunity in vivo by PD-1 blockadeNature, 2008
- PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progressionNature, 2006
- Restoring function in exhausted CD8 T cells during chronic viral infectionNature, 2005
- Immunology of hepatitis B virus and hepatitis C virus infectionNature Reviews Immunology, 2005